文献速递肿瘤 PET/CT

68Ga-FAPI与18F-FDG PET/CT在结肠系膜复发性未分化多形性肉瘤中的比较

68 Ga-FAPI Versus 18 F-FDG PET/CT in Recurrent Undifferentiated Pleomorphic Sarcoma of Colon Mesentery.
PubMed 文献 · Clin Nucl Med · 2022-05-19

一例56岁女性结肠系膜原发未分化多形性肉瘤术后约7个月,腹部增强CT示降结肠新发肿块提示复发。在临床试验中行68Ga-FAPI与18F-FDG PET/CT,68Ga-FAPI对结肠系膜、腹膜、盆腔淋巴结及肺转移灶摄取更高,提示其可能是有前景的显像剂。

要点

  • 结肠系膜复发性未分化多形性肉瘤及腹膜、盆腔淋巴结、肺转移灶在68Ga-FAPI PET/CT上摄取高于18F-FDG PET/CT。
  • 该病例提示68Ga-FAPI可能是评估未分化多形性肉瘤有前景的放射性药物。
  • 病例为56岁女性,原发肿瘤术后约7个月,腹部增强CT示降结肠新发肿块提示复发。

核心结论

  • 该病例显示68Ga-FAPI可能是评估未分化多形性肉瘤有前景的放射性药物。

研究设计与样本

  • 一例56岁女性结肠系膜原发未分化多形性肉瘤患者,约7个月前接受完整手术切除。
  • 腹部增强CT示降结肠新发肿块提示肿瘤复发可能性高,患者在临床试验中接受68Ga-FAPI与18F-FDG PET/CT检查以探查有无其他复发灶。

主要发现

  • 与18F-FDG PET/CT相比,结肠系膜、腹膜、盆腔淋巴结复发性未分化多形性肉瘤及肺转移灶在68Ga-FAPI PET/CT上显示更高摄取。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 56-year-old woman presented with primary undifferentiated pleomorphic sarcoma of colon mesentery underwent complete surgical resection approximately 7 months ago. Abdominal contrast-enhanced CT showed a new mass in the descending colon, suggesting a high probability of tumor recurrence. Under a clinical trial, the patient underwent 68 Ga-FAPI and 18 F-FDG PET/CT to detect whether there are additional recurrent lesions. Compared with 18 F-FDG PET/CT, the recurrent undifferentiated pleomorphic sarcoma of colon mesentery, peritoneum, pelvic lymph node, and lung metastases showed higher uptake in 68 Ga-FAPI PET/CT. This case showed that 68 Ga-FAPI might be a promising radiopharmaceutical in the evaluation of undifferentiated pleomorphic sarcoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zhang L, Liu Z, Jiang S, et al. 68 Ga-FAPI Versus 18 F-FDG PET/CT in Recurrent Undifferentiated Pleomorphic Sarcoma of Colon Mesentery. Clin Nucl Med. 2022. PMID: 35605050. doi:10.1097/RLU.0000000000004275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。